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Cultured proximal cells derived from transgenic mouse provide a
model to study drug toxicity. The effects of gentamicin on N-acetyl-13-
D-glucosaminidase (NAG) and acid phosphatase (AcP), two lysosomal
enzymes present in proximal renal tubule cells, were studied in the
PKSV-PCT cell line derived from proximal convoluted tubules from
the kidney of a transgenic mouse carrying SV4O large T antigen under
the control of the L-type pyruvate kinase gene. Gentamicin (400 jLg/ml
for 72 hr) did not alter cell viability, but significantly reduced cell
growth and favored the formation of myeloid bodies. Gentamicin (50 to
800 j.g/ml for 72 hr) decreased in a dose-dependent manner the
cellular NAG in PKSV-PCT cells and stimulated its secretion by 20 to
60%. Chloroquine (50 to 100 tm) and ammonium chloride (NH4CI, 30
mM), two lysosomotropic amines known to stimulate the secretion of
lysosomal enzymes in fibroblasts and macrophages, also stimulated
secreted NAG in PKSV-PCT cells. However, the effect of chloroquine
was less marked in PKSV-PCT cells than in cultured mouse 3T3
fibroblasts. Gentamicin induced lysosomal alkalinization but, in con-
trast to chloroquine and NH4CI, the aminoside strongly stimulated the
secretion of AcP. The secretion induced by gentamicin was non-
polarized, since the percentage of secreted NAG significantly increased
from both the apical and basal sides of PKSV-PCT cells grown on
permeable filters. Thus, these data suggest that gentamicin alters the
secretion of NAG and AcP by a non-specific pathway and indicate that
the PKSV-PCT cell line is a suitable system to examine the cellular
action of drugs in kidney proximal tubule cells.
Most renal injuries induced by drugs are due to alterations of
the proximal tubule epithelial cells. Many studies have focused on
the in vivo effects of antibiotics on the mammalian kidney [1—3],
and gentamicin is one of the most extensively studied. This
aminoglycoside preferentially accumulates all along the proximal
tubule [4, 5] and alters ion transport processes [61. One of the
major effects of gentamicin is to interfere with lysosomal function
by reducing lysosomal enzyme activities, such as cathepsins [7]
and N-acetyl-fJ-D-glucosaminidase (NAG) [3]. Other studies have
shown that gentamicin also induces the formation of myeloid
bodies, which have been attributed to a reduction in the activities
of phospholipase and sphyngomyelinase [8, 9]. The presence of
large quantities of the serum and tissue forms of NAG in the urine
from patients with renal desease and in urine following renal
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transplantation in the rat led to urinary N-acetyl-/3-D-glu-
cosaminidase, and especially B isoform excretion, being proposed
as an index of proximal tubule cell injury [10, 11]. To our
knowledge, the way in which the secretion of N-acetyl-13-D-
glucosaminidase by proximal tubule epithelial cells is induced by
gentamicin has not been studied in a suitable model of differen-
tiated cultured proximal tubule cells.
Primary cultures of proximal tubule cells from rabbit kidney
[12—141 have been used to study the in vitro effects of cytotoxic
drugs on membranous and cytosolic enzymes and on transport
processes [15, 161. However, primary cultures have certain restric-
tions, an important one being that they usually lose their differ-
entiated functions when they are subcultured. Renal proximal
tubule-like established cell lines, such as LLC-PK1, have also been
used to study the proximal nephrotoxicity of xenobiotics [17, 18].
However, the precise origin of these cells remains unclear, since
LLC-PK1 cells, for example, have both proximal and distal tubule
cell functions [19J.
We recently established two lines of differentiated proximal
tubule cells, PKSV-PCT and PKSV-PR, derived from proximal
convoluted (PCT) and late proximal (pars recta) tubules,
respectively, microdissected out from kidneys of L-PK/Tagl
transgenic mice carrying large T antigen placed under the
control of the rat L-type pyruvate kinase 5'-regulatory se-
quence [201. These cell lines remained fully polarized and
retained the main specific functions of the parental proximal
tubule cells [20—22]. Thus, these differentiated renal proximal
epithelial cell lines appear to be a suitable model to analyze the
functional and morphological effects of cytotoxic drugs on
proximal tubule cells.
The present study analyzed the effects of gentamicin on two
lysosomal enzymes, N-acetyl-/3-D-glucosaminidase (NAG: EC
3.2.1.30) and acid phosphatase (AcP: EC 3.1.3.2), that mature
differently [23, 24] in PKSV-PCT cultured cells. The primary
results indicate that gentamicin stimulates the secretion of NAG
in a dose-dependent fashion from both apical and basal sides
when cells are grown on permeable filters. Similarly to that
observed in fibroblasts and macrophages [23, 25—28], ammonium
chloride (NH4CI) and to a lesser extent chloroquine, two lysoso-
motropic amines which altered the pH of lysosomes [29], were
found to also stimulate the secretion of NAG, but unlike genta-
micin, had no effect on the secretion of AcP.
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Methods
Cell culture
The PKSV-PCT cells used in the present study were derived
from microdissected proximal convoluted tubules (PCT) of the
kidney of a L-PKJTag1 transgenic mouse [20]. Cells were cultured
in DMEM-HAM's F12, 1:1 (vol/vol); 30 n sodium selenate; 5
gIml transferin; 2 mrvi glutamine; 5 jxg/ml insulin; 50 nM dexa-
methasone; 5 nM triiodothyronin; 10 ng/ml epidermal growth
factor; 20 m'vi D-glucose; 2% heat-inactivated fetal calf serum
(FCS) and 20 m'vi D-glucose at 37°C in a 5% C02-95% air
atmosphere [20]. Cells were seeded in either 35 mm or 60 mm
Petri dishes or on semipermeable transparent filters precoated
with collagen (Transwell-COL, 0.4 tm pore size, 1.2 cm diameter;
Costar Europe Ltd., Badhoevedorp, Netherlands). Experiments
were also performed on cultured mouse 3T3 fibroblasts (provided
by Dr. P. Moullier, Institut Pasteur, Paris). 3T3 cells were cultured
with the same medium as described above containing 10%
heat-inactivated FCS at 37°C in a 5% C02-95% air atmosphere.
In all cases, the medium was changed every two days. Experiments
were performed on exponentially growing or confluent cells
between the 40th and 55th passages.
Specimens and enzyme assays
Kidney cortex homogenates were prepared [20]. Cultured cells
grown on Petri dishes were rinsed twice in phosphate buffered
saline (PBS), scraped off with a rubber policeman, centrifuged
(100 g, 5 mm) at 4°C, and stored at —70°C before use. Cortex
homogenates and pelleted cells were resuspended in 1 ml 10 mM
phosphate, pH 7, sonicated and then treated with Triton X-100
(0.1% vol:vol) for two hours at 4°C. The N-acetyl-/3-D-glu-
cosaminidase (NAG) activity of mouse kidney cortices, cultured
cell lysates, and culture medium was measured as essentially
described according to Bourbouze et al [30]. Aliquots from tissues
and cell lysates were incubated in 0.2 ml 50 m citric acid-sodium
citrate pH 4.6, 2.5 mivi 4-methylumbelliferyl-13-N-acetylglu-
cosaminide (MU-NAG, Sigma), 0.2 mg/ml BSA (Miles) for 10
minutes at 37°C. The reaction was stopped by adding 2.85 ml 400
mM glycine-NaOH, pH 10.8. The same procedure was used to
measure the NAG activity in culture medium, except that the
incubation time was 30 minutes. Acid phosphatase activity (AcP)
was determined by incubation under the same conditions with I
mM 4-methylumbelliferyl phosphate in 100 m sodium acetate-
acetic acid buffer pH 5, for 30 minutes at 37°C for cell lysates, and
60 minutes for culture medium. Since AcP is rather unstable in
solution, the stability of this enzyme was controlled on cell lysates.
AcP activity slightly decreased by 6.3% and 12.6% when cell
lysates were incubated at 37°C for 24 and 48 hours, respectively.
The fluorescence intensity of the 4-methylumbelliferone re-
leased was measured by fluorimetry (excitation 368 nm; emission
448 nm). For calibration, values of fluorescence intensity were
compared to the values obtained with 2.25 m quinine sulfate
solution. All measurements were performed in duplicate. Results
are expressed as xM 4-methylumbelliferone liberated/min/g pro-
tein or as n[cap]m/min/ml culture medium. The percentage of
NAG or AcP secreted in the culture medium was calculated from
the ratio of enzymatic activity in culture medium over the total
activity (medium plus cell lysate).
Lactic dehydrogenase (LDH) activity, a marker of non-specific
cell injury, was measured in cell lysates and culture media
according to Mitchell, Santone and Costa [311 using the standard-
ized S.F.B.C kit assay (Biotrol, France). Protein content was
measured by the method of Lowry et al [32] using BSA as
standard.
Ion exchange chromatography (FPLC)
NAG isoforms from tissues, cell lysate and culture media were
separated by FPLC on an anion exchange column (Mono-Q HR
5/5; Pharmacia, Les Ulis, France). Samples were passed through
PD1O columns (Pharmacia) equilibrated with 10 mrvi phosphate
buffer, pH 7. The excluded material was collected and passed
through 0.45 filters. A Mono-Q HR 5/5 column was equilibrated
with 10 m phosphate buffer, pH 7 and samples (500 d) were
injected into the column. Materials were eluted by isocratic
elution for five minutes, followed by two linear NaC1 gradients:
0 to 0.5 M NaCI for 10 minutes and 0.5 to 1 M NaCl for five
minutes. The column was pre-equilibrated with 10 m phosphate,
pH 7. The flow rate was 2 mi/mm and 0.7 ml fractions were
collected. The UV absorbance (280 nm) and the NAG activity of
each fraction were measured.
3H-thymidine incorporation studies
The cell growth was estimated by measuring the 3H-methyl
thymidine (S.A. 25 Ci/mmol; CEN Saclay, France) incorporated
into trichloracetic (TCA)-insoluble cell fractions of PKSV-PCT
cells as previously described [22]. Briefly, cells from individual
35-mm Petri dishes (seeded at 1 to 2 x i0 cells per dish)
incubated with or without gentamicin (400 jxg/ml) for 72 hours
were pulsed for the last six hours with 3H-methyl thymidine (0.5
jxCi/well), rinsed with 1 ml ice-cold PBS and incubated with 1 ml
TCA (5%). The TCA was removed and the cells were lyzed in 1
ml 0.3 M NaOH. The radioactivity measured by scintillation
counting was corrected for the number of cells measured for each
condition tested. In parallel, cell viability was estimated by trypan
blue exclusion.
Fluorescence studies
The fluorescence of 9-amino acridine and fluoresceinated dex-
tran (40 K FITC dextrans; Sigma) were used to visualize lyso-
somes. These compounds are markers of the intracellular acidic
lysosomal and endosomal compartments, which remain stable and
fluorescent in lysosomes [29, 33]. Confluent PKSV-PCT cells
grown on collagen-coated Petri dishes and incubated with chlo-
roquine, NH4C1 or gentamicin (see text and legend of Fig. 5),
were loaded with either 10 .LM 9-amino acridine or 1.5 mg/ml
FITC-dextrans for 20 minutes and 18 hours, respectively. The cells
were rinsed five times with PBS and examined under an inverted
microscope (Zeiss, Germany) equipped with epifluorescent optics
(x 40) (excitation 490 nm; emission 525 nm). All cells were
photographed using the same exposure time to allow comparison
of the fluorescence intensity.
Morphological studies
PKSV-PCT cells grown to confluency in 60-mm plastic Petri
dishes were maintained in the presence or absence of gentamicin
(400 jxg/ml) for 48 to 72 hours. They were then photographed
under an inversed microscope (Axiovert 10, Zeiss, Germany). For
electron microscopy, cells were fixed with 2% glutaraldehyde in
0.1 M cacodylate buffer, pH 7.2, rinsed in 0.1 M cacodylate,
post-fixed in 1% osmic acid, dehydrated in a series of ethanols (25
Fig. 1. FPLC profiles of NAG activity (arbitraiy unit) in mouse renal cortex (A), cell lysates from confluent PKSV-PCT (B) and medium from confluent
PKSV-PCT (C) cells after 24 hours in culture. Two peaks were identified, one eluted at 60 mi NaC1 (arrowhead) (NAG-I isoform), and the second eluted
at 160 mrvt NaCI (arrow) (NAG-A isoform). Symbols are: (U--U) NAG; (U— —U) NaC1.
to 100%), and embedded in Epoxy resin. Ultrathin sections were
cut on transversally orientated confluent cultures, conterstained
with uranyl acetate and lead citrate, and viewed in a Philips
electron microscope [201.
Statistical analysis
Results are means SEM of several experiments carried out in
duplicate or triplicate. Statistical analyses were performed using
the Student's t test.
Results
Identification of NAG in cultured cells
Confluent PKSV-PCT cells had substantial amounts of NAG.
The cellular NAG activity in PKSV-PCT (19.0 2.2 xmol min'
g protein', N = 4) was almost twice that of whole kidney cortex
(mouse kidney cortex: 11.4 0.1 xmol min g protein1, N =
4). Thus PKSV-PCT cultured cells have retained the expression of
the NAG lysosomal enzyme.
FPLC analyses were used to identify the NAG isoforms in
cultured cells. Figure 1 shows the elution profiles of NAG
isoforms from mouse kidney cortex, confluent PKSV-PCT cell
lysates, and medium after 24 hours of culture. The main mamma-
lian tissue isoforms were found in all of them. The NAG B
isoform, with an isoelectrical point (Ip) of 7, was eluted isocrati-
cally, the NAG A isoform, with an Ip of 5 was eluted at 160 mM
NaC1, and the intermediate isoform I was eluted at 60 mM NaCI.
NAG I was the major form recovered (Fig. 1, arrowhead). NAG
A was also present (Fig. 1, arrow) but the concentration was lower
than in rabbit kidney [261; little NAG B was present. Therefore,
the secreted and cellular NAG isoforms profiles from PKSV-PCT
cells were similar to the mouse kidney cortex.
Morphological and functional alterations induced by gentamicin
The effect of the aminoglycoside on the functions of cultured
cells were analyzed at concentrations below 1.4 mrvi (800 xWml),
which have been shown not to significantly alter Na,K-ATPase
pumps, apical membrane hydrolases, and sodium- and phosphate-
dependent glucose transporters in primary cultures of rabbit
kidney proximal tubule cells [16]. Untreated PKSV-PCT cells
were cuboid and formed domes (Fig. 2A). Cultured cells incu-
bated with gentamicin (400 tgIml) for 72 hours showed morpho-
logical changes. They maintained the cuboid shapes, but formed
fewer and smaller domes (Fig. 2C). Ultrastructurally, the gen-
tamicin-treated cells were flatter (Fig. 2D) than untreated cells
(Fig. 2B). The most striking change induced by gentamicin was the
formation of many myeloid bodies (Fig. 2E).
The morphological changes were not related to cell alterations,
since the percentage of viable cells (>85%), the protein content
per cell, the cell LDH activity and LDH in the culture medium,
used as an index of cell injury [27], were not significantly altered
by gentamicin (Table 1). However, cell growth kinetic studies
showed that gentamicin reduced the 3H-methyl thymidine incor-
porated into PKSV-PCT cells by 31% (Table 1). Taken together,
these results indicate that low concentration of gentamicin (400
xgIml) in culture medium altered lysosomes assessed by the
presence of many myeloid bodies and partially inhibited cell
growth without altering the viability of mouse cultured proximal
cells.
Influence of gentamicin on cellular and secreted NAG
The cellular and secreted NAG activities were then analyzed in
cell lysates and the cultured medium after incubating PKSV-PCT
cells with 400 xg/ml gentamicin for various times. The cellular
NAG activity in PKSV-PCT cells decreased significantly soon
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Fig. 2. Morphological appearance of PKSV-PCT proximal tubule cells treated with gentamicin. Light microscopy of confluent PKSV-PGF (A, C) cultured
in the absence (A) or presence (C) of gentamicin (400 rg/ml for 72 hr). Electron micrographs of confluent PKSV-PCT (B, D) cultivated in similar
conditions as described above. Compared to untreated cells (B), cells incubated with gentamicin appeared flatterened (D). Numerous myeloid bodies
were observed in gentamicin-treated cells (E). Bars: (A—C) 50 j.rm; (B—D) 2 jsm; (E) 1 jrm.
Table 1. Influence of gentamicin on the properties of PKSV-PCT cells
Control + Genta
Protein content pg/106 cells 115 40 117 27
LDH activity 1iinol/minlg protein 1449 426 1016 136
% of total LDH secreted in medium 0.5 0] 0.7 0.2
3H-Tdr (cpm/106 cells) 6756 411 4636 562
Protein content, LDH activity in cell lysates and medium and 3H-methyl
thymidine (3H-Tdr) incorporation were measured as described in Meth-
ods on Sets of PKSV-PCT cells grown on Petri dishes incubated with or
without gentamicin (400 rg/ml) for 48 hours. Results are mean SCM
from 5 to 6 experiments.
a P < 0.001 indicates significant difference vs. control values
after 48 hours of incubation with gentamicin (Fig, 3A), whereas
the aminoglycoside induced a significant and gradual increase in
the NAG secreted from two to five days (Fig. 3B). Results from
FPLC indicated that incubation for 72 hours with gentamicin did
not alter the profiles of cellular NAG isoforms (not shown). FPLC
analyses of the medium from control and gentamicin-treated
PKSV-PCT cells also indicated that the elution isoform profiles
remained identical (Fig. 4).
The specificity of the effect of gentamicin on NAG activity in
cultured proximal cells was assessed comparing the effects of
gentamicin and amikacin, a semisynthetic aminoglycoside with
low renal toxicity [34], on PKSV-PCT cells. Cells were incubated
with gentamicin and amikacin (50 to 800 xg/ml) for 72 hours
(Table 2). Amikacin had no significant effects on cellular activity
and secreted NAG, while concentrations of gentamicin above 100
ig/ml significantly reduced the cellular NAG activity and concen-
trations of 50 .tg/ml and above of gentamicin significantly in-
creased secreted NAG. Thus, the rate of NAG secretion de-
pended on the concentration of gentamicin used.
Effects of lysosomotropic amines and gentamicin on the secretion
of NAG andAcP
Previous studies have shown that the secretion of lysosomal
enzymes can be altered by changing the lysosomal pH [reviewed in
35]. Chloroquine and ammonium chloride, two agents which
alkalinize lysosomal pH, have been used to study the mechanisms
underlying the secretion of proteins in a variety of cell types
[25—28, 36—38]. To determine whether the aminoglycoside pro-
duces changes similar to those induced by weak bases, fluorescent
studies used to visualize lysosomes (Fig. 5) and measurements of
secreted NAG and AcP (Fig. 6) were performed on PKSV-PCT
cells incubated with chloroquine (25 to 100 jrM), NH4CI (30 mM)
for 24 hours, or with gentamicin (400 xg/ml) for 48 hours.
9-Amino acridine was first tested to identify the acidic organelles,
since it is relatively specific for lysosomes and phagolysosomes [39,
40]. Round-shaped intracytoplasmic structures in PKSV-PCT
cells fluoresced under the conditions tested (Fig. 5). However, the
pattern of labeling varied from one condition to another. In
untreated cells, the fluorescence was evenly distributed around
the nuclei, in organdIes of the same size forming regular punc-
tuate points (Fig. 5A). In 50 LrM chloroquine-treated cells, the
pattern of distribution of fluorescence was almost identical to that
observed in untreated cells (Fig. 5C). The distribution of fluores-
cence in NH4CI-treated cells was more intense and diffuse and
present in enlarged organelles (Fig. 5E), which could be swollen
lysosomes [29]. The labeling in gentamicin-treated cells was
uneven and in structures of different sizes (Fig. 5G). Experiments
with FITC-dextrans gave identical results; the fluorescence inten-
sity was slightly higher in chioroquine-treated cells (Fig. SD) than
in untreated cells (Fig. SB), and was much more marked in
NH4C1- and gentamicin-treated cells (Fig. S F, H). Since previous
studies showed that the intensity of FITC-dextrans increased with
726 Riccaldi et air Aminoglycoside toxicity in proximal cells
A B
70
60
**
*55
o 50
1)(I)
o 40
30(0
2 200
10
0
Fig. 3. Effects of gentamicin on cellular and
secreted NAG. NAG activity in cell lysates (A)
and the percentage of total NAG secreted (B)
in the culture medium were measured 1 to 5
days after cultivating confluent PKSV-PCT in
the absence (0, LI) or presence (•, •) of 400jsg/ml gentamicin. Values are means SEM
from six separate experiments performed in
2 3 4 duplicate. P < 0.05, < 0.01, < 0.001indicate significant differences as compared to
Time, days untreated cells.
Fig. 4. FPLC profiles of NAG activity (arbitra,y
unit) in medium from confluent PKSV-PCT
cultivated in the absence (A) or presence (B) of
gentamicin (400 jig/mi) for 48 hours. Note that
the elution profiles are identical. Symbols are:
(—i) NAG; (— —•) NaCl.
Table 2. Effects of gentamicin and amikacin on cellular NAG activity
and NAG secreted by PKSV-PCT cells
Gentamicin Amikacin
NAG NAG
Aminoglycoside Cell secreted Cell secreted
pg/mi lysate % lysate %
0 29.3 0.7 12.5 0.5 24.7 0.4 10.4 1.3
50 27.7 0.8 18.8 1.0" 26.9 0.5 11.6 0.3
100 26.6 0.4 21.2 0.5c 23.0 0.3 12.5 0.3
200 20.5 2.2a 28.3 0.7c 25.3 0.3 13.9 0.2
400 16.2 0.8c 37.5 1.9 24.8 0.9 14.5 0.4
800 10.8 0.8c 59.7 2.8' 25.0 0.4 14.9 0.6
The cellular NAG activity (J.Lmol min g protein') and the
percentage (%) of secreted NAG in the culture medium were measured
on confluent PKSV-PCT incubated without or with gentamicin or amika-
cm for 72 hours. Values are means SaM from three to four experiments
performed in duplicate.aP < 0.05, hP < 0.01, 'P < 0.001 indicate significant differences vs.
control values (0)
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pH [331, our results indirectly suggest that gentamicin, NH4C1,
and to a lesser extent chloroquine induced lysosomal alkaliniza-
tion. Although these results provided no direct estimation of
internal pH, they suggested that gentamicin affected the internal
lysosomal pH from PKSV-PCT cells, and that the aminoglycoside
was responsible for major changes in the size of the lysosomes.
Previous studies performed on human fibroblasts showed that
chloroquine and ammonium chloride stimulated the secretion of
lysosomal enzymes by different mechanisms [23, 25, 261. Since the
sensibility of the drugs tested may differ in fibroblasts and
proximal tubule cells, we first analyzed the effects of weak bases
on cellular and secreted NAG in mouse 3T3 cultured fibroblasts.
The results are summarized in Table 3. As already reported in
human cultured fibroblasts [231, chloroquine induced a dose-
dependent increase in the secretion of NAG and a significant
decrease in cellular NAG when 3T3 cells were incubated with 100
I.LM chloroquine. NH4CI also significantly stimulated the secretion
of NAG in 3T3 cells. We then compared the effects of chloroquine
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and NH4C1 incubated for 24 hours and gentamicin incubated for
48 hours on cellular and secreted NAG and AcP activities from
PKSV-PCT cultured cells grown on Petri dishes (Fig. 6). Whereas
low concentrations (25 to 50 xM) of chioroquine and NH4CI did
not alter cellular NAG activity, 100 j.LM chioroquine and 400 g/ml
gentamicin induced a decrease in NAG activity (untreated cells
22.3 0.6; + 100 xM chloroquine 17.3 1.2; + gentamicin 17.1
0.2 xmol min' g protein1) (Fig. 6, upper panel).
Contrasting with the results obtained on cultured mouse 3T3
fibroblasts (Table 3), 25 xM chioroquine had no effect on secreted
NAG by PKSV-PCT cells (Fig. 6). Higher concentrations of
chloroquine were required to induce the stimulation of secreted
NAG by these cells. A 24 hours of incubation with NH4C1 (30 mM)
also increased secreted NAG. The effects of these two lysosomo-
tropic amines was, however, less pronounced than the action of
gentamicin (Fig. 6, lower panel). Thus, these results indicated that
gentamicin strongly stimulated the secreted NAG in PKSV-PCT
cells, but in contrast with 3T3 fibroblasts, sub-toxic concentrations
of chioroquine had no effect on the secretion of this lysosomal
enzyme.
Chioroquine (25 to 100 LM) and NH4CI (30 mM) did not
significantly affect the cellular AcP activity (Fig. 6), a hydrolase
:
Ca
tl)
U)
C
E
Ci)0
0
25
20
15
10
5
0
35
30 **
25
iiiLJ1• -8'
20
15
IEE1Ei!i
i:., 30
a)
25
.C ()
a)
-D 20
OQ- 15
10
8'
Fig. 6. Influence of chioroquine, NH4CI and gentamicin on NAG and AcP
activities. NAG and AcP activities in cell lysates and the percentage of total
NAG and AcP secreted in the culture medium were measured on
confluent PKSV-PCT incubated without (U) or with (LI) various concen-
trations of chloroquine (Chloro, 25 to 100 .tM), ammonium chloride
(NH4C1, 30 mM) for 24 hours and gentamicin (Genta, 400 jig/mi) for 48
hours. Values are means SEM from (N) determinations indicated in the
bars. *p < 0.05, **p < 001, ***p < 0.001 indicate significant differences
vs. Basal values.
Fig. 5. Gentamicin induces changes in PKSV-PCT cell lysosomal fluores-
cence. Fluorescence of PKSV-PCT cells loaded with 9-amino acridinc (A,
C, E, G) and fluid phase pinocytosed FITC-dextrans (B, B, F, H). Cells
incubated without (A, B) or with 50 jiM chioroquine (C, D), 30 ms NH4CI
for 24 hours (E, F) or 400 jig/mi gentamicin for 48 hours (G, H), were
loaded with 10 JiM 9-amino acridine for 20 minutes or 1.5 mg/mi
FITC-dextrans for 18 hours. White and gray dots represent fluorescent
lysosomes which have incorporated the dyes. Bars: (A, C, E, G) 10 jim;
(B, D, F, H) 10 Jim.
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Cell lysate NAG secreted %
Control 14.0 1.2 18.7 3.3
Chloroquine (25 ISM) 14.0 2.3 37•3 74a
Chloroquine (50 JLM) 14.5 1.5 46.7 5.6"
Chloroquine (100 /LM)
NH4CI (30 mM)
7.7 1.8"
14.3 1.5
59.6 2.7"
37.1 375
The cellular NAG activity (smol min g protein) and the
percentage (%) ofsecreted NAG in the culture medium were measured
on confluent 3T3 cells incubated without (control) or with chloroquine
and NH4CI for 24 hours. Values are means SEM from 5—12 determina-
tions performed on three passages.
"P < 0.05, "p < 0.01, '"P < 0.001 indicate significant differences vs.
control values
present in endosomes and lysosomes that, unlike NAG [23] and
other lysosomal enzymes [411, does not bear the mannose-6-
phosphate lysosonial targeting signal [24]. In contrast, gentamicin
(400 jig/mI) caused a significant decrease in cellular AcP activity
(Fig. 6). Gentamicin also induced a dramatic increase (+ 369%) in
acid phosphatase secretion, whereas chloroquine and NH4C1 had
no significant effects (Fig. 6, lower panel). Thus, these results
suggested that gentamicin strongly stimulated the exocytosis of
AcP from lysosomes in proximal cultured cells.
Gentamicin and NH4CI induce nonpolarized secretion of NAG
The membrane side (apical or basolateral) of NAG secretion
altered by the lysosomotropic amines and aminoglycoside was
analyzed using PKSV-PCT cells grown on permeable filters.
Confluent cell layers were incubated on both the apical and basal
sides with 50 jiM chloroquine, 30 mrvi NH4CI for 24 hours or 400
jig/mI gentamicin for 72 hours. As already observed on cells
grown on Petri dishes, the cellular NAG activity was slightly lower
in gentamicin-treated cells, hut was not affected by chloroquine or
NH4C1 (Fig. 7). In the absence of aminoglycoside, 13% of the
total NAG activity was recovered in the medium bathing the
apical side of the cells and 23% recovered in the medium bathing
the basal side of the cells (Fig. 7). Chloroquine did not signifi-
cantly affect secreted NAG from both the apical side and the basal
side of the cells. As for PKSV-PCT grown on plastic Petri dishes,
gentamicin stimulated the secretion of NAG on PKSV-PCT cells
grown on filters. NAG was not preferentially secreted via the
apical or basal sides of the cells, since the same relative increases
in NAG, +61% and +63%, were measured in the medium
bathing the apical and basal sides of the cells, respectively (Fig. 7).
Almost identical results were obtained with NH4CI: incubation for
24 hours induced a +65% increase in NAG in the medium
bathing the apical side and a +39% increase in that on basal side
of PKSV-PCT cells grown on permeable filters (Fig. 7). These
results suggest thus that PKSV-PCT grown on filters are resistant
to the action of chioroquine and that gentamicin, like NH4C1,
stimulates NAG secreted via a non-polarized pathway [37].
Discussion
The results show that the model of proximal renal cultured cells
derived from L-PK/Tagl transgenic mouse can be used to study
the action of nephrotoxic drugs. The established mouse kidney
cell line PKSV-PCT offers several advantages over primary cul-
tures of proximal tubule cells from the rabbit kidney [12—14, 16].
Cell lysate
Apical side
*
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____ ____
Basal Chloro NH4CI Genta
Fig. 7. Effects of weak bases and gentamicin on the apical and basolateral
secretion of NAG by PKSV-PCT proximal tubule cells grown on filters.
Confluent PKSV-PCT cells grown on filters were cultured without (Basal,
open bars) or with 50 JiM chloroquine (Chloro, ), 30 mro NH4CI () for
24 hours or 400 jig/mI gentamicin (Genta, U) for 48 hours. NAG activities
from cell lysate and medium bathing the apical and the basal sides were
measured as described in the Methods. Values are means SEM from 5 to
6 determinations. *p < 0.05, ""P < 0.001 indicate significant differences
vs. Basal values.
Cells can be produced in large amounts, remain differentiated for
long-term passages, and have retained the phenotypic expression
of their parental cells [20, 22].
Results of enzymatic studies on microdissected tubule segments
from rabbit kidneys showed that the NAG activity was restricted
to the proximal tubule [3t)]. PKSV-PCT retains the expression of
NAG and exhibit the same predominant NAG I and A isoforms
found in intact mouse kidney. The relative distributions of these
isoforms and the lack of B isoform observed in rabbit kidney [30]
TabJe 3. Effects of lysosomotropic amines on cellular NAG activity
and secreted NAG by mouse 3T3 fibroblasts
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reflect the species difference of the enzyme [42]. Thus, as in the
pig and rat liver, NAG I is the major form in the mouse kidney.
PKSV-PCT cultured cells had the same profiles of NAG isoforms
as the mouse kidney cortex homogenate, indicating that this
immortalized proximal cell line has retained the NAG-specific
expression of mouse kidney.
One of the main effects of gentamicin is to alter lysosomes [9,
341 Morphological studies showed that gentamicin favors the
production of myeloid bodies, characteristic of altered lysosomes,
by the PKSV-PCT cultured cells, in the same way as do rats
treated with high doses of gentamicin [2, 3]. Gentamicin also
dramatically increases the amount of NAG secreted by cells.
These effects depend on the dose of gentamicin used and appear
to be rather specific, since identical concentrations of amikacin do
not significantly affect NAG activity or its secretion. The increase
in secreted NAG during the first three days of incubation do not
appear to be directly linked to cell dammage, since cell viability
and cellular LDH activity and LDH recovered in the medium
were not affected by the concentrations of gentamicin used in the
present study. However, gentamicin impaired the rate of cell
growth and reduced the dome formation.
Many studies have been devoted to the cellular traffic of
lysosomal enzymes. Previous studies have shown that altering the
acidic pH of the endosomal and lysosomal compartments and
endocytic vesicles [29], with lysosomotropic amines may perturb
the movements of many proteins in various cell systems. For
exemple, NH4C1 impairs the stockage of von Willebrand factor (a
secreted protein) in Weibel-Pallade granules in endothelial cells
and causes the secretion of this factor [36]. It also favors the
release of proteins from secretion granules of the parotid gland by
direct exocytosis and vesicular secretion [38]. The mechanisms by
which lysosomotropic amines increase the release of lysosomal
enzymes to the culture medium have been extensively studied in
cultured fibroblasts and macrophages. Lysosomal enzymes, syn-
thetized in the endoplasmic reticulum in a glycosylated precursor
form, bind to the mannose-6-phosphate (Man-6-P) receptor and
are targeted into lysosomes [reviewed in 41, 43]. Lysosomotropic
amines disrupt transport of lysosomal enzyme by alkalinizating
acidic compartments, inhibit dissociation of newly synthetized
lysosomal enzymes from the Man-6-P receptors, prevent the
recycling of receptors and increase the sorting of lysosomal
enzymes [25, 44]. However, lysosomotropic amines have low
effects on the secretion of acid phosphatase, another lysosomal
enzyme which seems not require the Man-6-P system for its
targeting into lysosomes [24].
Amines may have also different effects depending on the
compounds and the cell types considered. In cultured fibroblasts,
NH4C1 and low concentrations (25 to 50 xM) of chloroquine divert
newly synthetized lysosomal enzymes which are sorted via a
constitutive pathway to the culture medium [25, 281 while higher
concentrations of chloroquine (100 xM) induce an important
decrease in lysosomal enzymes activities and promote the release
of lysosomal contents into the medium [42].
Like in 3T3 fibroblasts, NH4CI stimulates the secretion of NAG
by PKSV-PCT. In contrast, there are marked differences in the
effect of chloroquine on PKSV-PCT and 3T3 cells. As already
reported in the literature, subtoxic concentrations of chloroquine
(25 to 50 jxM) increase secreted NAG by 3T3 cells, but do not
significantly affect secreted NAG by proximal cultured cells gruwn
on Petri dishes or filters. Only 100 xM chloroquine, toxic for
fibroblasts [421, significantly stimulate the rate of secreted NAG
by PKSV-PCT cells. These findings seem to be a particular feature
of proximal tubule cells since we also observed that 25 to 50 .LM
chloroquine do not affect the rate of secreted NAG by primary
cultures of rabbit proximal tubule cells grown on Petri dishes (not
shown). Thus, these results suggest that proximal tubule cells in
culture are quite resistant to the action of chloroquine.
The fact that gentamicin induces both a decrease in cellular
NAG and an increase in secreted NAG in PKSV-PCT cells
suggests that the aminoside alters both exocytosis of processed
forms from lysosomal content and newly synthetized lysosomal
enzymes. However, the present results do not illustrate the
mechanism by which gentamicin operates. Since gentamicin alters
lysosomes, assessed by the high frequency of myeloid bodies, does
not impair the NAG isoform pattern recovered in culture me-
dium, and strongly stimulates the secretion of AcP, it is suggested
that the aminoglycoside induces the release of lysosomal enzymes
from altered lysosomes. Indeed, the secretion of acid phosphatase
was not influenced by chloroquine and NH4C1. Thus, the impor-
tant increase in the rates of secreted NAG and AcP induced by
gentamicin in the PKSV-PCT cells indicated that the lysosomes
from these proximal tubule cultured cells appear to be particularly
sensitive to the action of gentamicin similarly to the parental cells
[9, 34] from which they were derived.
In a previous study Caplan et al [37] showed that NH4C1
stimulates the apical and basolateral secretion of components of
the extracellular matrix and lysosomal proteins from MDCK
canine renal cells grown on filters. In the present study, we also
found that the secretion of NAG induced by gentamicin, as well as
NH4C1, appears to be non-polarized, since both agents stimulate
the release of NAG from both apical and basal sides of PKSV-
PCT cells grown on filters. Taken together these results suggest
that the secretion of NAG induced by gentamicin follows an
unregulated pathway not directly related to proximal cell polarity.
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